AXIN2 and neoplasm: Considering that E-cadherin/α-catenin tumor suppressors strongly induce YAP phosphorylation as an upstream regulator of the Hippo [25,28], these results indicate that Axin2 specifically inhibits the Hippo pathway in CRC.